서방형 부형제 시장 보고서(2026년)
Sustained Release Excipients Global Market Report 2026
상품코드 : 1957838
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,745,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,750,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,755,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

서방형 부형제 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 15억 1,000만 달러에서 2026년에는 16억 3,000만 달러에 이르고, CAGR 8.2%로 성장할 전망입니다. 지난 수년간의 성장은 만성질환 유병률 증가, 서방형 정제 사용 확대, 고분자 화학의 발전, 제네릭 의약품 제조 확대, 지속형 제제의 규제적 수용 등의 요인에 기인하는 것으로 보입니다.

서방형 부형제 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 23억 달러에 이르고, CAGR은 8.9%를 나타낼 전망입니다. 예측 기간 동안의 성장은 지속형 주사제에 대한 수요 증가, 생물학적 제제 및 특수 의약품의 성장, 약물 전달 기술 연구개발에 대한 투자 확대, 환자 중심 제제에 대한 수요, 신흥 시장에서의 의약품 제조 확대에 기인할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 제어된 약물 전달 시스템에 대한 수요 증가, 지속형 제제에서 폴리머 사용 확대, 경구용 지속형 제형 채택 증가, 마이크로 캡슐화 및 코어셀레이션 기술 확대, 환자 복약 순응도 및 투약 빈도 감소에 대한 관심 증가 등이 있습니다.

개인 맞춤형 의료에 대한 수요 증가는 향후 몇 년 동안 서방형 첨가제 시장의 성장을 견인할 것으로 예측됩니다. 맞춤형 의료는 환자의 고유한 유전자, 단백질, 기타 생물학적 요인을 분석하여 정밀의료 접근법을 통해 개인별 맞춤 치료법을 설계하고 제공하는 것을 말합니다. 이러한 맥락에서 각 환자의 요구 사항에 따라 맞춤형 약물 제제를 만들 수 있는 서방형 첨가제는 필수적입니다. 예를 들어, 미국 헬스케어 단체인 '맞춤의료연합'에 따르면, 2024년 2월 현재 FDA는 2023년 희귀질환 환자를 위한 16건의 새로운 맞춤치료제를 승인했습니다. 이는 2022년 6건에서 증가한 수치입니다. 그 결과, 개인 맞춤형 의료의 채택 확대가 지속성 첨가제 시장의 성장을 가속하고 있습니다.

서방형 첨가제 시장의 주요 기업들은 약물 제제 효율 향상, 납기 단축, 제어 방출 프로파일 실현을 지원하기 위해 다기능성 폴리머 플랫폼과 같은 첨단 솔루션에 초점을 맞추었습니다. 다기능성 폴리머 플랫폼은 핫멜트 압출, 용해도 향상형 분무건조 등의 제형 기술과 호환성을 유지하면서 속효성, 지연성, 지속성 약물 방출을 가능하게 하는 첨가제입니다. 예를 들어, 2024년 9월 독일에 본사를 둔 에보닉은 다름슈타트(Darmstadt)에 EUDRAGIT 폴리머를 위한 신규 분무건조 설비를 가동하기 시작했습니다. 이 시설은 생산 능력의 증강, 납기 단축을 실현하고 기존 생산 네트워크와 완벽하게 통합되어 있습니다. 지역 쓰레기 소각시설에서 공급되는 친환경 전력과 증기를 이용하여 연간 1,000톤 이상의 CO2 배출량을 절감하고 있습니다. IPEC-GMP 의약품 가이드라인에 따라 운영되며, 수성 분산액 생산 라인과 직접 연결된 이 시설은 운송 비용을 절감하고 공급망을 효율화합니다. 여기서 생산되는 폴리머는 즉시 방출형, 지연 방출형, 지속 방출형 제제 설계를 가능하게 하여 에보닉의 경구용 약물 전달 솔루션의 세계 허브 기능을 강화하고 효율적인 의약품 혁신을 지원할 수 있는 역량을 강화합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

LSH
영문 목차

영문목차

Sustained-release excipients are pharmaceutical ingredients or additives used in drug formulations to enable controlled or extended release of active pharmaceutical ingredients (APIs) over time. These excipients help regulate the release rate and duration of drug action, enhancing therapeutic effectiveness and patient adherence.

The main types of sustained-release excipients include gelatin, polymers, minerals, sugars, alcohol, and chitosan. Gelatin is a protein derived from collagen, the most abundant protein in animal connective tissues such as skin, bones, and tendons. These excipients can be administered via multiple routes, including oral, intramuscular, subcutaneous, transdermal, vaginal, ophthalmic, intravenous, and others. Various technologies are used in their formulation, such as targeted delivery, microencapsulation, the Wurster process, transdermal systems, implants, and coacervation.

Tariffs have influenced the sustained release excipients market by increasing costs associated with importing specialized polymers, gelatin, and mineral-based raw materials used in controlled drug delivery formulations. These impacts are most visible in polymer- and technology-intensive segments such as microencapsulation, targeted delivery, and implants, with Asia-Pacific and Europe being highly affected due to their dependence on cross-border raw material sourcing. Rising tariffs have pressured manufacturers to optimize formulations, renegotiate supplier contracts, and localize production. On the positive side, tariffs are encouraging domestic excipient manufacturing and innovation, strengthening regional supply chains and reducing long-term dependency on imports.

The sustained release excipients market research report is one of a series of new reports from The Business Research Company that provides sustained release excipients market statistics, including sustained release excipients industry global market size, regional shares, competitors with a sustained release excipients market share, detailed sustained release excipients market segments, market trends and opportunities, and any further data you may need to thrive in the sustained release excipients industry. This sustained release excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sustained release excipients market size has grown strongly in recent years. It will grow from $1.51 billion in 2025 to $1.63 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to growth in chronic disease prevalence, increased use of modified release tablets, advancements in polymer chemistry, expansion of generic drug manufacturing, regulatory acceptance of sustained release formulations.

The sustained release excipients market size is expected to see strong growth in the next few years. It will grow to $2.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to rising demand for long acting injectables, growth in biologics and specialty drugs, increasing investment in drug delivery R&D, demand for patient centric formulations, expansion of pharmaceutical manufacturing in emerging markets. Major trends in the forecast period include rising demand for controlled drug delivery systems, growing use of polymers in sustained release formulations, increasing adoption of oral sustained release dosage forms, expansion of microencapsulation and coacervation technologies, focus on patient compliance and reduced dosing frequency.

The increasing demand for personalized medicine is expected to drive the growth of the sustained-release excipients market in the coming years. Personalized medicine involves analyzing a patient's unique genes, proteins, and other biological factors to design and deliver treatments tailored to individual needs using precision medicine approaches. Sustained-release excipients are essential in this context, as they enable the creation of drug formulations customized for each patient's requirements. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based healthcare organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022. As a result, the rising adoption of personalized medicine is fueling the expansion of the sustained-release excipients market.

Leading companies in the sustained-release excipients market are focusing on advanced solutions, such as multifunctional polymer platforms, to improve drug formulation efficiency, reduce delivery times, and support controlled-release profiles. Multifunctional polymer platforms are excipients capable of enabling immediate, delayed, and sustained drug release while remaining compatible with formulation technologies like hot melt extrusion and solubility-enhancing spray drying. For instance, in September 2024, Evonik, a Germany-based company, began operations at a new spray drying facility at its Darmstadt site for EUDRAGIT polymers. The facility increases production capacity, shortens delivery times, and integrates fully with existing production networks. It uses green electricity and steam from local waste incineration, cutting CO2 emissions by over 1,000 tons annually. Operating under IPEC-GMP pharmaceutical guidelines and directly linked to the production of aqueous dispersions, the facility reduces transportation and streamlines the supply chain. The polymers produced support immediate, delayed, and sustained-release formulations, enhancing Evonik's global hub for oral drug delivery solutions and strengthening its ability to support efficient pharmaceutical innovation.

In March 2024, Roquette, a France-based provider of pharmaceutical excipients, acquired IFF Pharma Solutions for an undisclosed amount. The acquisition is intended to reinforce Roquette's position in the pharmaceutical excipients market. IFF Pharma Solutions, a US-based company, specializes in producing sustained-release excipients-ingredients used in pharmaceutical formulations to control the release rate of active pharmaceutical ingredients (APIs).

Major companies operating in the sustained release excipients market are BASF SE, Ashland Global Holdings Inc, Colorcon Inc, Evonik Industries AG, Lubrizol Corporation, Merck KGaA, Roquette Freres, Shin Etsu Chemical Co Ltd, JRS Pharma GmbH Co KG, SPI Pharma Inc, Croda International Plc, Lonza Group AG, Chemische Fabrik Budenheim KG, Asahi Kasei Corporation, DuPont de Nemours Inc, Dow Chemical Company, Eastman Chemical Company, Gattefosse SAS, Balchem Corporation, Associated British Foods plc, Ransom Naturals Ltd, Cellulose Solutions Private Limited

North America was the largest region in the global sustained release excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sustained release excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sustained-release excipients market consists of sales of ethyl cellulose, lipid-based excipients, waxes, fatty acids, polyethylene glycol (PEG), copovidone, and osmotic agents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sustained Release Excipients Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses sustained release excipients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for sustained release excipients ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sustained release excipients market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Sustained Release Excipients Market Characteristics

3. Sustained Release Excipients Market Supply Chain Analysis

4. Global Sustained Release Excipients Market Trends And Strategies

5. Sustained Release Excipients Market Analysis Of End Use Industries

6. Sustained Release Excipients Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Sustained Release Excipients Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Sustained Release Excipients Total Addressable Market (TAM) Analysis for the Market

9. Sustained Release Excipients Market Segmentation

10. Sustained Release Excipients Market Regional And Country Analysis

11. Asia-Pacific Sustained Release Excipients Market

12. China Sustained Release Excipients Market

13. India Sustained Release Excipients Market

14. Japan Sustained Release Excipients Market

15. Australia Sustained Release Excipients Market

16. Indonesia Sustained Release Excipients Market

17. South Korea Sustained Release Excipients Market

18. Taiwan Sustained Release Excipients Market

19. South East Asia Sustained Release Excipients Market

20. Western Europe Sustained Release Excipients Market

21. UK Sustained Release Excipients Market

22. Germany Sustained Release Excipients Market

23. France Sustained Release Excipients Market

24. Italy Sustained Release Excipients Market

25. Spain Sustained Release Excipients Market

26. Eastern Europe Sustained Release Excipients Market

27. Russia Sustained Release Excipients Market

28. North America Sustained Release Excipients Market

29. USA Sustained Release Excipients Market

30. Canada Sustained Release Excipients Market

31. South America Sustained Release Excipients Market

32. Brazil Sustained Release Excipients Market

33. Middle East Sustained Release Excipients Market

34. Africa Sustained Release Excipients Market

35. Sustained Release Excipients Market Regulatory and Investment Landscape

36. Sustained Release Excipients Market Competitive Landscape And Company Profiles

37. Sustained Release Excipients Market Other Major And Innovative Companies

38. Global Sustained Release Excipients Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Sustained Release Excipients Market

40. Sustained Release Excipients Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기